NM_001369.3:c.5272-15delT

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001369.3(DNAH5):​c.5272-15delT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 3668 hom., cov: 0)
Exomes 𝑓: 0.24 ( 381 hom. )

Consequence

DNAH5
NM_001369.3 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.617

Publications

0 publications found
Variant links:
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
DNAH5 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 5-13841918-CA-C is Benign according to our data. Variant chr5-13841918-CA-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 351096.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.527 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH5NM_001369.3 linkc.5272-15delT intron_variant Intron 32 of 78 ENST00000265104.5 NP_001360.1 Q8TE73

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH5ENST00000265104.5 linkc.5272-15delT intron_variant Intron 32 of 78 1 NM_001369.3 ENSP00000265104.4 Q8TE73
DNAH5ENST00000681290.1 linkc.5227-15delT intron_variant Intron 32 of 78 ENSP00000505288.1 A0A7P0Z455

Frequencies

GnomAD3 genomes
AF:
0.314
AC:
32804
AN:
104540
Hom.:
3671
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.255
Gnomad AMI
AF:
0.372
Gnomad AMR
AF:
0.344
Gnomad ASJ
AF:
0.313
Gnomad EAS
AF:
0.550
Gnomad SAS
AF:
0.346
Gnomad FIN
AF:
0.394
Gnomad MID
AF:
0.272
Gnomad NFE
AF:
0.320
Gnomad OTH
AF:
0.334
GnomAD4 exome
AF:
0.237
AC:
112952
AN:
475680
Hom.:
381
Cov.:
0
AF XY:
0.233
AC XY:
59978
AN XY:
256968
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.186
AC:
2275
AN:
12222
American (AMR)
AF:
0.198
AC:
3686
AN:
18652
Ashkenazi Jewish (ASJ)
AF:
0.219
AC:
2948
AN:
13442
East Asian (EAS)
AF:
0.290
AC:
7731
AN:
26634
South Asian (SAS)
AF:
0.175
AC:
7604
AN:
43460
European-Finnish (FIN)
AF:
0.229
AC:
6006
AN:
26218
Middle Eastern (MID)
AF:
0.215
AC:
416
AN:
1934
European-Non Finnish (NFE)
AF:
0.248
AC:
76322
AN:
308318
Other (OTH)
AF:
0.240
AC:
5964
AN:
24800
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.382
Heterozygous variant carriers
0
4807
9614
14422
19229
24036
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1340
2680
4020
5360
6700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.314
AC:
32792
AN:
104534
Hom.:
3668
Cov.:
0
AF XY:
0.317
AC XY:
14955
AN XY:
47224
show subpopulations
African (AFR)
AF:
0.255
AC:
7159
AN:
28092
American (AMR)
AF:
0.344
AC:
2993
AN:
8702
Ashkenazi Jewish (ASJ)
AF:
0.313
AC:
926
AN:
2962
East Asian (EAS)
AF:
0.549
AC:
1714
AN:
3122
South Asian (SAS)
AF:
0.347
AC:
933
AN:
2690
European-Finnish (FIN)
AF:
0.394
AC:
747
AN:
1896
Middle Eastern (MID)
AF:
0.273
AC:
42
AN:
154
European-Non Finnish (NFE)
AF:
0.320
AC:
17529
AN:
54760
Other (OTH)
AF:
0.334
AC:
465
AN:
1392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
961
1922
2883
3844
4805
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 05, 2015
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.62
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35337694; hg19: chr5-13842027; COSMIC: COSV54203833; API